SLC6A4 and Alzheimer disease: These “early” increases in the density of SERT, which may decrease the level of extracellular 5-HT, contrast the degenerative reductions in the levels of several serotonergic components, including SERT, which are typically observed in the brain of aged amyloidosis models [13, 14] and advanced cases of AD [15].